Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation

FASEB Journal

Volumn 12, Issue 10, 1998, Pages 801-811

  Kondo, Seiji ^a   Tanaka, Yoshikazu ^b   Kondo, Yasuko ^a   Hitomi, Masahiro ^a   Barnett, Gene H ^a   Ishizaka, Yukihito ^c   Liu, Jinbo ^a   Haqqi, Talat ^a   Nishiyama, Akiko ^a   Villeponteau, Bryant ^d   Cowell, John K ^a   Barna, Barbara P ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^d GERON CORPORATION   (United States)

Author keywords

CDKI; ICE; Oglionucleotide; p27; Tumor cells; Tumorigenicity

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN P21; PROTEIN P27; TELOMERASE;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL MOTILITY; CELL SUBPOPULATION; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALS; APOPTOSIS; CASPASE 1; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYSTEINE ENDOPEPTIDASES; DNA, NEOPLASM; GLIOMA; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; TELOMERASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

MUS MUSCULUS;

EID: 0031750443     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Schoenberg, B. S. (1083) Oncology of the Nervous System (Walker, M. D., ed) pp. 1-30, Nifhoff, Boston
2. Collins, M. K. L., Sinnett-Smith, J. W., and Rozengurt, E. (1983) Platelet-derived growth factor treatment decreases the affinity of the epidermal growth factor receptors of Swiss 3T3 cells.J. Biol. Chem. 258, 11689-11693
3. Libermann, T. A., Nusbaum, H. R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M. D., Ullrich, A., and Schlessinger, J. (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumors of glial origin. Nature. (London) 313, 144-147
4. Sidransky, D., Mikkelsen, T., Schwechheimer, K., Rosenblum, M. L., Cavene, W. K., and Vogelstein, B. (1992) Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature (London) 355, 846-847
5. Mehle, C., Piatyszek, M. A., Ljungberg, B., Shay.J. W., and Roos, G. (1996) Telomerase activity in human renal cell carcinoma. Oncogene 13, 161-166
6. Blackburn, E. H. (1991) Structure and function of telomeres. Nature (London) 350, 569-573
7. de Lange, T. (1994) Activation of telomerase in a human tumor. Pror. Natl. Acad. Sci. USA 91, 2882-2885
8. Harley, C. B., Futcher, A. B., and Greider, C. W. (1990) Telomeres shorter during aging of human fibroblasts. Nature (London) 345, 458-460
9. Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Geen, D. K., and Allshire, R. C. (1990) Tclomere reduction in human colorectal carcinoma and with aging. Nature (London) 346, 866-868
10. Greider, C. W., and Blackburn, E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413
11. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. (1992) Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J. 11, 1921-1929
12. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay.J. W. (1994) Specific association of human telomerase activity with immortal cell lines and cancer. Science 266, 2011-2015
13. Broccoli, D., Young. J. W., and de Lange, T. (1995) Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. USA 92, 9082-9086
14. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J.W. (1995) Telomerase activity in small-cell and non-small-cell lung cancers. J Natl. Cancer Inst. 87, 895-902
15. Hiyama, E., Yokoyama, T., Tatsumoto, N., Hiyama, K., Imamura, Y., Murakami, Y., Kodama, T., Piatyszek, A. P., Shay, J. W., and Matsuura, Y. (1995) Telomerase activity in gastric cancer. Cancer Res. 55, 3258-3262
16. Chiu. C. P., Dragowska, W., Kim, N. W., Vaziri, H., Yui, J., Thomas, T. E., Harley, C. B., Lansdorp, P. M. (1996) Differential expression of telomerase activity in hemopoietic progenitors from adult human bone marrow. Stem Cells 14, 239-248
17. Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C.W., and Villeponteau, B. (1995) The RNA component of human telomerase. Science 269, 1236-1241
18. Yuan, J., Shaham, S., Ledoux, S., Ellis, H. M., and Horvitz, H. R. (1993) The C. ekgans cell death gene ced-3 encodes a protein similar to mammalian interleukin-lβ-covertihg enzyme. Cell75, 641-652
19. Miura, M., Zru, H., Rotello, R., 'Hartwieg, E. A., and Yuan, J. (1993) Induction of apoptosis in fibroblasts by IL-β-convcrting enzyme, a mammalian homolog of the G elegans cell death gene ced-3. Cell 75, 653-660
20. Kondo, S., Barna, B. P., Morimura, T., Takeuchi, J.,Yuan, J., Akbasak, A., and Barnett, G. (1995) H. Interleukin-lβ-converting enzyme (ICE) mediates cisplatin-inchiced apoptosis in malignant glioma cells. Cancer Res. 55, 6166-6171
21. Kondo, S., Kondo, Y., Yin, D., Barnett, G. H., Kaakaji, R., Peterson, J. W., Morimura, T., Kubo, H., Takeuchi, J., and Barna, B. P. (1996) Involvement of interleukin-lβ-converting enzyme in apoptosis of bFGF-deprived murine aortic endothelial cells. FASEB J. 10, 1192-1197
22. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825
23. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78, 59-66
24. Toyoshima, H., and Hunter, T. (1994) p27, a novel inhibitor of Gl cyclin-Cdk protein kinase activity, is related to p21. Cell 78, 67-74
25. Van Meir, E. G., Kikuchi, T., Tada, M., Li, H., Diserens, A. C., Wojcik, B. E., Huang, H. J. S., Friedmann, T., de Tribolet, N., and Cavenee, W. K. (1994) Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54, 649-652
26. Kondo, Y., Kondo, S., Tanaka, Y., Haqqi, T., Barna, B. P., and Cowell, J. K. (1998) Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatininduced apoptosis. Oncogene In press
27. Kondo, S., Barnett, G. H., Hara, H., Morimura, T., and Tafceuchi, J. (1995) MDM2 protein confers the resistance of human glioblastomn cell line to cisplatin-induced apoptosis. Oncogene 10, 2001-2006
28. Yin, D., Kondo, S., Takeuchi, J., and Morimura, T. (1994) Induction of apoptosis in marine ACTH-secieting pituitary adcnoma cells by bromocriptine. FEES Lett. 339, 73-75
29. Kondo, S., Morimura, T., Barnett, G. H., Kondo, Y., Peterson, J. W., Kaakaji, R., Takeuchi, J., Toms. S.A., Liu, J., Werbel, B., and Barna, B. P. (1996) The transforming activities of MDM2 in cultured neonatal rai astrocytes. Oncogene 13, 1773-1779
30. Barna, B. P., Estes, M. L., Pettay, J., Iwasaki, K., Zhou, P., and Barnett, G. H. (1995) Human astrocyte growth regulation: interleukin-4 sensitivity and receptor expression.J. Neuwimmunol. 60, 75-81
31. Kondo, S., Yin, D., Monmura, T., Kubor, H., Nakatsu, S., and Takeuchi, J. (1995) Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-re-sistant human glioblastoma cells. Br. J. Cancer. 71, 282-289
32. Fox, P. L., Sa, G., Dobrowolski, S. F., and Stacey, D. W. (1993) The regulation of endothelial cell motility by p21 ras. Oncogene 9, 3519-3526
33. Rutka, J. T., and Smith, S. L. (1993) Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity. Cancer Res. 53, 3624-3631
34. Rutka, J. T., Hubbard, S. L., Fukuyama, K., Matsuzawa, K., Dirks, P. B., and Becker, L. E. (1994) Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells. Cancer Res. 54, 3267-3272
35. Okada, H., Yoshida, J., Sokabe, M., Wakabayashi, T., and Hagiwara, M. (1996) Suppression of CD44 expression decreases migration and invasion of human glioma cells. Int. J. Cancer. 66, 255-260
36. Kranonburg. O., Schamhorst, V., Van der Eb, A. J., Zantema, A. (1995) Inhibition of cyclin-dependent kinase activity triggers neuronal differentiation of mouse neuroblastoma cells. J. Cell Biol 131, 227-234
37. Liu, M., Lee, M.-H., Cohen, M., Bommakanti, M., and Freedman, L. P. (1996) Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the my-elomonocytic cell line U937. Genes & Dev. 10, 142-153
38. Wang, J., and Walsh, K. (1996) Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359-361
39. Counter, C. M., Gupta, J., Harley, C. B., Leber, B., and Bacchetti, S. (1995) Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 85, 2315-2320
40. Chadeneau, C., Hay, K., Hirte, H. W., Gallinger, S., and Bacchetti, S. (1995) Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res. 55, 2533-2536
41. 1NK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasu. Mol. Cell. Biol. 15, 4745-4753
42. Strahl, C., and Blackburn, E. H. (1996) Effect of reserve transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol. Cell. Biol. 16, 53-65
43. Wyllie, A. H. (1987) Cell death. Int. Rev. Cytol. 17, 755-785
44. Kaufman, S. H. (1989) Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etooside, camptotecin, and other cytotoxic anti-cancer drugs; a cautionary note. Cancer Res. 49, 5870-5878
45. Eastman, A. (1990) Activation of programmed cell death by anticancer agents: cisplatin as a model system. Cancer Cells 2, 275-280
46. Kondo, S., Yin, D., Morimura, T., Oda, Y., Kikuchi, H., and Takeuchi, J. (1994) Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression. Cancer Res. 54, 2928-2933
47. Kondo, S., Yin, D., Aoki, T., Takahashi, J. A., Morimura, T., and Takeuchi, J. (1994) bcl-2 gene prevents apoplosis of basic fibroblast growth factor-deprived murine aortic endotheliac cells. Exp. Cell Res. 213, 428-432
48. Levine, A. J., Momand, J., and Finlay, C. A. (1991) The p53 tumour suppressor gene. Nature (London) 351, 453-456
49. Yonish-Ruuach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. (1991) Wild-type p53 induces apoptosis of myeloid leukamic cells that is inhibited by interleukin-6. Nature (London) 352, 345-340
50. Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., and Wyllie, A. H. (1993) Thymocyte apo ptosis induced by p53-depcndent and independent pathways. Nature (London) 362, 849-852
51. Pritsche, M., Haessler, C., and Brandner, G. (1993) Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene 8, 307-318
52. Lowe, S. W., Earl-Ruley, H., Jacks, T., and Housman, D. E. (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. cell 74, 957-967
53. Wang, L., Miura, M., Bergeron, L., Zhu, H., and Yuan, J. (1994) Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 78, 739-750
54. Sharma, H. W., Sokoloski, J. A., Ferez, J. R., Maltese, J. Y., Sartorelli, A. C., Stein, C. A., Nichols, G., Khaled, Z., Telang, N.T., and Narayanan, R. (1995) Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 92, 12343-12346
55. Bestilny, L. J., Brown, C. B., Miura, Y., Robertson, L. D., and Riabowol, K. T. (1996) Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines. Cancer Res. 56, 3796-3802
56. 1 to S-phase transition. Annu. Rev. Cell. Biol. 8, 529-561
57. Pines, J. (1993) Cyclins and cyclin-dependent kinases; take your partners. Trends Biochem. Sci. 18, 195-197
58. Sherr, C.J. (1993) Mammalian d cyclins. Cell 73, 1059-1065
59. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes & Dev. 9, 639-649
60. Serrano, M., Hannon, G., and Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK4. Nature (London) 366, 704-707
61. Xiong, Y., Zhang, H., Beach, D. (1993) Subunit rearrangement of the cyclin-dependent kinases is associated with cellular trans formation. Gents & Dev. 7, 1572-1583
62. Zhu, X., Kumar, R., Mandai, M., Shanna, N., Sharma, H. W., Dhingra, U., Sokoloski, J. A., Hsiano, R., and Narayanan, R. (1996) Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA 93, 6001-6095
63. Blasco, M. A., Lee, H.-W., Hande, M.P., Samper, E., Lansdorp, P. M., DePinho, R. A., and Greider, C. W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34
64. Bednarek, A., Budunova, I., Slaga, T. J., and Aldaz, C. M. (1995) Increased telomerase activity in mouse skin pre-malignant progression. Cancer Res. 55, 4566-4569
65. Chadeneau, C., Siegel, P., Harley, C. B., Muller, W., and Bacchetti, S. (1995) Telomerase activity in normal and malignant murine tissues. Qncogene 11, 893-898
66. Blasco, M. A., Rizen, M., Greider, C. W., and Hanahan, D. (1996) Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat. Genet. 12, 200-204
67. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E., and de Lange, T. (1996) Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol. 16, 3765-3772
68. Kondo, S., Kondo, Y., Li, G., Silver-man, R.H., and Cowell, J. K. (1998) Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA. Oncogene In press